| 000 | 01792 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515003247.0 | ||
| 264 | 0 | _c20060309 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0724-8741 | ||
| 024 | 7 |
_a10.1007/s11095-005-8355-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFanciullino, Raphaelle | |
| 245 | 0 | 0 |
_aDevelopment of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cDec 2005 |
||
| 300 |
_a2051-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 |
_aInosine _xadministration & dosage |
| 650 | 0 | 4 | _aLasers |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aScattering, Radiation |
| 650 | 0 | 4 |
_aThymidylate Synthase _xantagonists & inhibitors |
| 700 | 1 | _aGiacometti, Sarah | |
| 700 | 1 | _aAubert, Claude | |
| 700 | 1 | _aFina, Frederic | |
| 700 | 1 | _aMartin, Pierre-Marie | |
| 700 | 1 | _aPiccerelle, Philippe | |
| 700 | 1 | _aCiccolini, Joseph | |
| 773 | 0 |
_tPharmaceutical research _gvol. 22 _gno. 12 _gp. 2051-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11095-005-8355-9 _zAvailable from publisher's website |
| 999 |
_c15851021 _d15851021 |
||